ProFunds Pharmaceuticals UltraSector Svc PHPSX
- NAV / 1-Day Return 18.30 / −1.67 %
- Total Assets 3.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.780%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Trading—Leveraged Equity
- Investment Style Mid Blend
- Min. Initial Investment 15,000
- Status Open
- TTM Yield —
- Turnover 272%
USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 12:13 AM GMT+0
Morningstar’s Analysis PHPSX
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 36.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Soc 5.18% , 2/1/2024 | 7.97 | 267,000 | Cash and Equivalents |
Hsb 5.15% , 2/1/2024 | 4.77 | 160,000 | Cash and Equivalents |
Organon & Co Ordinary Shares | 4.56 | 152,914 | Healthcare |
Catalent Inc | 4.19 | 140,512 | Healthcare |
Cra 5.19% , 2/1/2024 | 3.94 | 132,000 | Cash and Equivalents |
Axsome Therapeutics Inc | 3.87 | 129,733 | Healthcare |
Viatris Inc | 3.62 | 121,160 | Healthcare |
Merck & Co Inc | 3.51 | 117,760 | Healthcare |
Elanco Animal Health Inc | 3.48 | 116,534 | Healthcare |
Intra-Cellular Therapies Inc | 3.37 | 112,997 | Healthcare |